DeepMed Research

MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast Cancer

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Drug: cisplatin
Drug: bevacizumab
Drug: doxorubicin
Drug: cyclophosphamide
Drug: paclitaxel

First Posted Date: 2007-12-24

Last Posted Date: 2021-05-26

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 51

Registration Number: NCT00580333

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States

Bipolar Disorder in Pregnancy and the Postpartum Period: Predictors of Morbidity

Completed

Conditions: Bipolar Disorder
Psychiatric Morbidity
Neonatal Outcome

First Posted Date: 2007-12-24

Last Posted Date: 2014-08-12

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 118

Registration Number: NCT00580268

Locations: 🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸
Massachusetts Geral Hospital, Boston, Massachusetts, United States

Bone Marker Assessment of Multiple Myeloma Patients Treated With Aminobisphosphonates

Phase 2

Completed

Conditions: Multiple Myeloma

Interventions: Drug: Zoledronic acid

First Posted Date: 2007-12-20

Last Posted Date: 2017-03-10

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 29

Registration Number: NCT00577642

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Mitochondrial Function in Pediatric Obesity

Conditions: Obesity
Insulin Resistance

First Posted Date: 2007-12-20

Last Posted Date: 2012-04-30

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 110

Registration Number: NCT00577174

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Study of Maca Root to Treat Sexual Dysfunction Associated With the Treatment Regimen for Bipolar Disorder in Females

Phase 3

Terminated

Conditions: Bipolar Disorder
Sexual Dysfunction

Interventions: Drug: Maca Root
Drug: Placebo

First Posted Date: 2007-12-18

Last Posted Date: 2020-09-25

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 8

Registration Number: NCT00575328

Locations: 🇺🇸
Depression Clinical and Research Program, Massachusetts General Hospital, Boston, Massachusetts, United States

Splinting for Dupuytren's Contracture Release

Completed

Conditions: Dupuytren's Disease

First Posted Date: 2007-12-18

Last Posted Date: 2010-11-16

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 60

Registration Number: NCT00575458

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Study of Maca Root for the Treatment of Antidepressant-Induced Sexual Dysfunction in Females

Phase 3

Completed

Conditions: Antidepressant Induced Sexual Dysfunction

Interventions: Drug: Maca Root
Drug: Placebo

First Posted Date: 2007-12-05

Last Posted Date: 2020-08-26

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 45

Registration Number: NCT00568126

Locations: 🇺🇸
Depression Clinical and Research Program, Massachusetts General Hospital, Boston, Massachusetts, United States

Erlotinib in Patients With Resected, Early Stage NSCLC With Confirmed Mutations in the EGFR

Phase 2

Completed

Conditions: Non-small Cell Lung Cancer

Interventions: Drug: Erlotinib

First Posted Date: 2007-12-04

Last Posted Date: 2018-12-11

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 100

Registration Number: NCT00567359

Locations: 🇺🇸
Stanford University, Stanford, California, United States
🇺🇸
Massachusetts General Hosptial, Boston, Massachusetts, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

and more 5 locations

The Use of Galantamine HBr (Reminyl) in Electroconvulsive Therapy: Impact on Mood and Cognitive Functioning

Phase 3

Completed

Conditions: Major Depression
Bipolar Depression
Schizoaffective Disorder

Interventions: Drug: Placebo
Drug: Razadyne

First Posted Date: 2007-12-04

Last Posted Date: 2012-12-03

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 39

Registration Number: NCT00566735

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

CBT for Adherence and Depression in Diabetes

Not Applicable

Completed

Conditions: Depression
Diabetes Mellitus

Interventions: Behavioral: Enhanced treatment as usual plus adherence training
Behavioral: Enhanced treatment as usual plus CBT-AD

First Posted Date: 2007-11-27

Last Posted Date: 2018-01-08

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 87

Registration Number: NCT00564070

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy